Targeted cancer therapy -Nanobots
About Nanobots therapy
Nanobots in targeted cancer therapy are emerging as a revolutionary approach, offering precise drug delivery directly to tumor cells while minimizing damage to healthy tissue. They are still largely in experimental stages but show immense promise for the future of oncology.
Working of Nanobots in Cancer Therapy
- Targeted Binding: Nanobots can be engineered to recognize and bind specifically to cancer cells, sparing healthy tissue.
- Drug Delivery: They carry chemotherapy drugs or genetic material and release them only at the tumor site, reducing systemic side effects.
- Magnetic Guidance: Some nanobots are controlled externally using magnetic fields or MRI scanners, allowing doctors to steer them through blood vessels.
- Tumor Penetration: Unlike conventional drugs, nanobots can penetrate dense tumor tissue and even enter cells, ensuring deeper therapeutic reach.
Comparison: Nanobot Therapy vs Conventional Cancer Treatments
| Feature |
Nanobot Therapy |
Chemotherapy/Radiation |
| Precision |
High (targets cancer cells directly) |
Low (affects healthy cells too) |
| Side Effects |
Reduced (localized action) |
Significant (hair loss, nausea, immune suppression) |
| Delivery Method |
Guided via magnetic/MRI or biochemical signals |
Systemic drug infusion or radiation beams |
| Stage of Development |
Pre-clinical/early trials |
Widely established |
| Cost (future outlook) |
Potentially lower (less hospitalization, fewer side effects) |
High (long-term treatment, supportive care) |
Current Research Highlights
- Indian Institute of Science (IISc), Bangalore: Developed magnetic nanorobots that can travel through blood and tissue, binding preferentially to cancer cells.
- Polytechnique Montréal, Canada: Researchers steer drug-loaded nanobots in animal models using MRI scanners.
- Global Research: Nanobots are being explored for both diagnosis and therapy, including detecting cancer at early stages.
Challenges & Risks
- Clinical Trials Pending: Most nanobot therapies are still in pre-clinical or animal testing stages.
- Safety Concerns: Long-term effects of nanobots in the human body remain unknown.
- Manufacturing Complexity: Designing and producing nanobots at scale is technologically demanding.
- Regulatory Approval: It may take years before nanobot therapies are widely available.
Download Pdf
